| Literature DB >> 20207151 |
Yoshihisa Nakada1, Thomas D Aicher, Yvan Le Huerou, Timothy Turner, Scott A Pratt, Stephen S Gonzales, Steve A Boyd, Hiroshi Miki, Toshihiro Yamamoto, Hiroshi Yamaguchi, Koki Kato, Shuji Kitamura.
Abstract
A series of diacylethylenediamine derivatives were synthesized and evaluated for their inhibitory activity against DGAT-1 and pharmacokinetic profile to discover new small molecule DGAT-1 inhibitors. Among the compounds, N-[2-({[1-phenyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]carbonyl}amino)ethyl]-6-(2,2,2-trifluoroethoxy)pyridine-3-carboxamide 3x showed potent inhibitory activity and excellent PK profile. Oral administration of 3x to mice with dietary-induced obesity resulted in reduced body weight gain and white adipose tissue weight. Copyright 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20207151 DOI: 10.1016/j.bmc.2010.01.067
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641